
Lupin Limited has informed the Exchange regarding a press release dated February 16, 2024, titled "Lupin Receives Approval from U.S. FDA for MinzoyaTM (Levonorgestrel and EthinylEstradiol Tablets, USP and Ferrous Bisglycinate Tablets).".
Filed with NSE ·

Lupin Limited has informed the Exchange regarding a press release dated February 16, 2024, titled "Lupin Receives Approval from U.S. FDA for MinzoyaTM (Levonorgestrel and EthinylEstradiol Tablets, USP and Ferrous Bisglycinate Tablets).".
6ix hasn’t read this filing yet.
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin